Table 2.
Diagnosis | Stage | Age | Gender | |
---|---|---|---|---|
1 | NSCLC | IV | 65 | F |
2 | NSCLC | IIB | 58 | M |
3 | NSCLC | IV | 49 | F |
4 | NSCLC | IV | 42 | F |
5 | MESO | III | 50 | M |
6 | NSCLC | IB | 84 | F |
7 | NSCLC | IV | 82 | M |
8 | SCLC | IV | 63 | F |
9 | NSCLC | IV | 60 | F |
10 | NSCLC | IIIA | 72 | M |
11 | NSCLC | IIIB | 65 | F |
12 | NSCLC | IV | 59 | F |
13 | NSCLC | IIIB | 78 | M |
14 | SCLC | IIIB | 58 | M |
15 | NSCLC | IV | 42 | F |
16 | NSCLC | IV | 62 | M |
17 | NSCLC | IV | 80 | M |
18 | NSCLC | IIIA | 68 | F |
19 | MESO | III | 72 | M |
20 | SCLC | IIIB | 56 | M |
21 | NSCLC | IV | 66 | M |
NSCLC non-small cell lung cancer, SCLC small cell lung cancer, MESO mesothelioma